Maartje Los

6.3k total citations
80 papers, 2.0k citations indexed

About

Maartje Los is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Maartje Los has authored 80 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 34 papers in Pulmonary and Respiratory Medicine and 25 papers in Surgery. Recurrent topics in Maartje Los's work include Colorectal Cancer Treatments and Studies (11 papers), Renal cell carcinoma treatment (10 papers) and Gastric Cancer Management and Outcomes (10 papers). Maartje Los is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Renal cell carcinoma treatment (10 papers) and Gastric Cancer Management and Outcomes (10 papers). Maartje Los collaborates with scholars based in Netherlands, Germany and United States. Maartje Los's co-authors include Jeanine M.L. Roodhart, Emile E. Voest, Haiko J. Bloemendal, Miranda J. Velthuis, Frans Erdkamp, Charlotte N. Steins Bisschop, Marlies Verhaar, Elsken van der Wall, Petra H. Peeters and Daan ten Bokkel Huinink and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Maartje Los

79 papers receiving 2.0k citations

Peers

Countries citing papers authored by Maartje Los

Since Specialization

Citations

This map shows the geographic impact of Maartje Los's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maartje Los with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maartje Los more than expected).

Fields of papers citing papers by Maartje Los

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maartje Los. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maartje Los. The network helps show where Maartje Los may publish in the future.

Co-authorship network of co-authors of Maartje Los

This figure shows the co-authorship network connecting the top 25 collaborators of Maartje Los. A scholar is included among the top collaborators of Maartje Los based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maartje Los. Maartje Los is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patient-reported outcomes during first-line palliative systemic therapy alternated with pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: a single-arm phase II trial (CRC-PIPAC-II) 2024 ·Surgical Endoscopy ·(unknown), (unknown), Koen P. Rovers, Emma C. E. Wassenaar, Geert‐Jan Creemers, Maartje Los, Jacobus W. A. Burger, Simon W. Nienhuijs, Onno Kranenburg, Marinus J. Wiezer, Robin J. Lurvink, Djamila Boerma, (unknown)	2
2	The Effects of Being Informed About Chemotherapy-Related Cognitive Symptoms With And Without Self-Affirmation on Perceived Cognitive Symptoms of Breast Cancer Patients: A Randomized Prospective, Longitudinal Study 2022 ·Clinical Breast Cancer ·(unknown), Sanne B. Schagen, Susanne Brouwer, Jacobien M. Kieffer, Inge O. Baas, Maartje Los, Gabe S. Sonke, Enny Das	4
3	Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial 2021 ·Journal of Surgical Oncology ·Willem J. Koemans, Rosa T. van der Kaaij, Emma C. E. Wassenaar, Djamila Boerma, Henk Boot, Karolina Sikorska, Maartje Los, Cecile Grootscholten, Koen J. Hartemink, Alexander A. F. A. Veenhof, Liudmila L. Kodach, Pétur Snæbjörnsson, Johanna W. van Sandick	14
4	Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results 2020 ·British journal of surgery ·Rosa T. van der Kaaij, Emma C. E. Wassenaar, Willem J. Koemans, Karolina Sikorska, Cecile Grootscholten, Maartje Los, Alwin D. R. Huitema, J.H.M. Schellens, A.A.F.A. Veenhof, Koen J. Hartemink, Arend G. J. Aalbers, Bert van Ramshorst, Djamila Boerma, Henk Boot, Johanna W. van Sandick	35
5	Contradiction between amide‐CEST signal and pH in breast cancer explained with metabolic MRI 2019 ·NMR in Biomedicine ·(unknown), Wybe J. M. van der Kemp, (unknown), Thijs van Dalen, Maartje Los, Hanneke W.M. van Laarhoven, Peter R. Luijten, Maurice A. A. J. van den Bosch, Dennis W. J. Klomp, Jannie P. Wijnen	22
6	The relevance of geriatric assessment for older patients receiving palliative chemotherapy 2019 ·Journal of Geriatric Oncology ·(unknown), Sophie A. Kurk, Jeanine M.L. Roodhart, (unknown), Thomas Pelgrim, Josephine M. I. Vos, Maaike Söhne, (unknown), Peter G. Noordzij, Ankie M.T. van der Velden, Maartje Los	10
7	Tolerability, Safety, and Outcomes of Neoadjuvant Chemoradiotherapy With Capecitabine for Patients Aged ≥ 70 Years With Locally Advanced Rectal Cancer 2018 ·Clinical Colorectal Cancer ·Lotte Jacobs, (unknown), Daan ten Bokkel Huinink, Haiko J. Bloemendal, Martijn Intven, Anke B. Smits, Bas L. Weusten, Peter D. Siersema, Niels van Lelyveld, Maartje Los	5
8	Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study 2017 ·JMIR Research Protocols ·Rosa T. van der Kaaij, H.J. Braam, Henk Boot, Maartje Los, Annemieke Cats, Cecile Grootscholten, Jan H.M. Schellens, Arend G. J. Aalbers, Alwin D. R. Huitema, Catherijne A. J. Knibbe, Djamila Boerma, Marinus J. Wiezer, Bert van Ramshorst, Johanna W. van Sandick	13
9	Cost-effectiveness analysis of an 18-week exercise programme for patients with breast and colon cancer undergoing adjuvant chemotherapy: the randomised PACT study 2017 ·BMJ Open ·Anne M. May, (unknown), Miranda J. Velthuis, Elsken van der Wall, Charlotte N. Steins Bisschop, Maartje Los, Frans Erdkamp, Haiko J. Bloemendal, Marnix A.J. de Roos, Marlies Verhaar, Daan ten Bokkel Huinink, Petra H.M. Peeters, G. Ardine de Wit	43
10	Relative dose intensity as a proxy measure of quality and prognosis in adjuvant chemotherapy for breast cancer in daily clinical practice 2017 ·European Journal of Cancer ·(unknown), (unknown), Mariëtte J Agterof, (unknown), Maartje Los, P.C. de Jong	22
11	Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group 2017 ·Annals of Oncology ·Johannes J.M. Kwakman, Lieke H. J. Simkens, Johan M. van Rooijen, Agnès J. van de Wouw, Albert J. ten Tije, G.J. Creemers, Mathijs P. Hendriks, Maartje Los, R J van Alphen, M. Polée, E.W. Muller, Ankie M.T. van der Velden, Theo van Voorthuizen, Miriam Koopman, Linda Mol, Erik van Werkhoven, Cornelis J.A. Punt	47
12	Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial 2016 ·Annals of Oncology ·Fabian Trillsch, Sven� Mahner, Felix Hilpert, Lucy Davies, (unknown), Gunnar B. Kristensen, Antonella Savarese, Peter Vuylsteke, Maartje Los, Flora Zagouri, Laurence Gladieff, Jalid Sehouli, Chee Khoon Lee, Val Gebski, Éric Pujade-Lauraine	20
13	Alternating Treatment With Pazopanib and Everolimus vs Continuous Pazopanib to Delay Disease Progression in Patients With Metastatic Clear Cell Renal Cell Cancer 2016 ·JAMA Oncology ·Geert A. Cirkel, Paul Hamberg, Stefan Sleijfer, O. J. L. Loosveld, M. Wouter Dercksen, Maartje Los, Marco B. Polée, Franchette van den Berkmortel, Maureen J.B. Aarts, Laurens V. Beerepoot, Gerard Groenewegen, Martijn P. Lolkema, Metin Tascilar, Johanneke E.A. Portielje, Frank Peters, Heinz‐Josef Klümpen, Vincent van der Noort, John B.A.G. Haanen, Emile E. Voest	25
14	A randomized phase II study to compare the efficacy of upfront bi-monthly rotations between pazopanib (PAZ) and everolimus (EVE) versus sequential treatment of first-line PAZ and second-line EVE until progression in patients with metastatic clear cell renal cell cancer (ccRCC) (ROPETAR trial). 2016 ·Journal of Clinical Oncology ·Geert A. Cirkel, Paul Hamberg, Stefan Sleijfer, O. J. L. Loosveld, Wouter Dercksen, Maartje Los, John B.A.G. Haanen, Marco B. Polée, Franchette van den Berkmortel, Maureen J.B. Aarts, Laurens V. Beerepoot, Gerard Groenewegen, Martijn P. Lolkema, Metin Tascilar, (unknown), Frank Peters, Heinz‐Josef Klümpen, (unknown), Emile E. Voest	1
15	Severe fluoropyrimidine toxicity due to novel and rare DPYD missense mutations, deletion and genomic amplification affecting DPD activity and mRNA splicing 2016 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·André B. P. Kuilenburg, Judith Meijer, (unknown), Doreen Dobritzsch, Rutger Meinsma, Maartje Los, (unknown), Lida Zoetekouw, Rob L. H. Jansen, Vincent O. Dezentjé, (unknown), Roel J.W. van Kampen, Jens Michael Hertz, Raoul C. M. Hennekam	36
16	Diffusion-weighted MRI for Early Prediction of Treatment Response on Preoperative Chemoradiotherapy for Patients With Locally Advanced Rectal Cancer 2015 ·Annals of Surgery ·Lotte Jacobs, Martijn Intven, Niels van Lelyveld, M.E.P. Philippens, (unknown), Kees A. Seldenrijk, Maartje Los, O. Reerink	35
17	Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences 2015 ·Journal of Cancer Education ·Linda Oostendorp, Petronella B. Ottevanger, Agnès J. van de Wouw, Aafke H. Honkoop, Maartje Los, Winette T.A. van der Graaf, Peep F. M. Stalmeier	19
18	SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer 2015 ·European Urology ·Christian Eichelberg, Walter L. Vervenne, Maria De Santis, Ludwig Fischer von Weikersthal, Peter J. Goebell, Christian Lerchenmüller, Uwe Zimmermann, Monique M.E.M. Bos, Werner Freier, (unknown), Michael Staehler, Sascha Pahernik, Maartje Los, M. Schenck, Anne Flörcken, (unknown), Kirsten Hauswald, (unknown), (unknown), Maurice Stephan Michel	111
19	Effects of an Exercise Program in Colon Cancer Patients undergoing Chemotherapy 2015 ·Medicine & Science in Sports & Exercise ·Jonna K. van Vulpen, Miranda J. Velthuis, Charlotte N. Steins Bisschop, Noémie Travier, (unknown), Frank Backx, Maartje Los, Frans Erdkamp, Haiko J. Bloemendal, Miriam Koopman, Marnix A.J. de Roos, Marlies Verhaar, (unknown), Elsken van der Wall, Petra H. Peeters, Anne M. May	107
20	Response to influenza virus vaccination during chemotherapy in patients with breast cancer 2011 ·Annals of Oncology ·A. Meerveld-Eggink, Okke de Weerdt, Ankie M.T. van der Velden, Maartje Los, Annette W.G. van der Velden, Jacqueline M. Stouthard, Marten R. Nijziel, Matthijs Westerman, Aart Beeker, Ruud van Beek, Guus F. Rimmelzwaan, Ger T. Rijkers, Douwe H. Biesma	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact